← Back to patent-cliff list
YKYY-029
Tier C — Watch / tradeYKYY-029
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Nucleic acid drug
Type
Targets：AGT
Indications (approved)：Hypertension
Regional status
US
Phase I
2025-07-23
EU
-
China
Phase II
2026-04-24
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of YKYY-029?
Approved indications include: Hypertension.
When does the YKYY-029 patent expire?
No public expiry year is available for YKYY-029 yet; this page updates once verified.
How do I get a quote for YKYY-029 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29